Medifron DBT Co., Ltd. (KOSDAQ:A065650) agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd. (KOSDAQ:A214270) on April 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,140 KRW | -1.38% | -2.28% | -21.76% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2,140 KRW | -1.38% | -2.28% | 52.93M | ||
1,453 KRW | -1.36% | +0.69% | 90.62M | ||
1st Jan change | Capi. | |
---|---|---|
-21.76% | 52.93M | |
+16.78% | 7.07B | |
-17.98% | 1.74B | |
-3.60% | 1.28B | |
-15.38% | 1.07B | |
+13.45% | 560M | |
+20.53% | 478M | |
-34.43% | 477M | |
-52.35% | 461M | |
+10.55% | 426M |
- Stock Market
- Equities
- A214270 Stock
- News FSN Co., Ltd.
- Medifron DBT Co., Ltd. agreed to acquire 31.8% stake in Fingerlabs Co., Ltd. from FSN Co., Ltd..